Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
5.00    0.00 (0.00%)
Bid:
5.00
Ask:
5.16
Spread: 0.16 (3.20%)
Market Cap: £43.49m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

HY2025 Trading Update

9 Oct 2024 07:00

RNS Number : 4432H
Revolution Beauty Group PLC
09 October 2024
 

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

HY2025 trading update

Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, is today providing an update on trading for the six months ended 31 August 2024.

First half financial summary

Total net sales in the first half of FY25 declined 20% to £72m (HY24: £90m), driven by the planned simplification of the product portfolio and the associated discontinuation of unproductive SKUs. The decline also reflects significant stock clearance activity in the first half of FY24.

By contrast, the net sales from the Company's core range of SKUs grew 6% in the first half, with growth accelerating to 16% in the second quarter versus the prior year.

Excluding stock provisions, Underlying Adjusted EBITDA was £3.1m in the first half (HY24: £3.5m(1)). Underlying sales channel margins improved as efficiencies and cost savings were realised from running a simplified brand portfolio. The Group's cost savings programmes remain on track, with operating costs, excluding marketing costs, decreasing 31% and administrative costs decreasing 25% year on year. Marketing increased 8% versus prior year, with investments in brand marketing to underpin future growth of core products.

As previously disclosed, Revolution Beauty continues to focus on clearing slow-moving discontinued inventory from previous years to generate cash. As a result, the Group has determined that it is necessary to recognise a one-off, non-cash stock provision of £11.3m in the first half to reflect the Net Realisable Value of the remaining old inventory, which will be excluded from Underlying Adjusted EBITDA. This will allow management to realise value and generate cash for future operations.

The Company had cash balances of £6.8m at 31 August 2024 and a fully drawn RCF of £32 million.

FY25 outlook

Reflecting the Group's first half performance, Revolution Beauty is updating its full year guidance. Sales for FY25 are now expected to decline year on year at a slightly slower rate than in H1, with a return to growth in the fourth quarter as a number of the Group's new strategic growth initiatives take effect, and this growth is expected to accelerate through FY26.

With the continuing momentum in the underlying business, as gross margins further strengthen in the second half of the year and as cost saving programmes continue to deliver, Underlying Adjusted EBITDA is expected to be at least in line with FY24 as previously guided, prior to the one-off stock provision.

Strategic progress

Revolution Beauty has continued to deliver on its Reigniting the Revolution strategy during the first half. This includes encouraging progress with existing and new retailers, through both digital and physical channels.

The Group has agreed a new relationship with DM Germany, Germany's number one mass beauty retailer, where Revolution Beauty will launch in more than 850 stores in January 2025. Revolution Beauty is also expanding into 250 new Boots stores in the UK in October 2024. In the US, Walmart will carry a full assortment of Revolution Beauty products in more than 1800 stores from January 2025, and its new Amazon US shop, launched in HY25, is growing ahead of plan.

Lauren Brindley, Revolution Beauty CEO, commented:

"In the last six months, we have made great progress in our Reigniting the Revolution strategy. We have reduced our SKU portfolio significantly, enabling improved underlying gross margin performance, on a core set of SKUs that are growing globally. This year is a transformational year for the Company, as we focus on simplifying the business, improving our operational efficiency and positioning ourselves for profitable and sustained success.

We expect a return to growth in Q4, as we begin landing our new growth initiatives, including a reinvigorated pipeline of make-up innovation, the launch of our new Skincare range and the global expansion of our budget brand, Relove. I remain highly confident that our Reigniting the Revolution strategy will deliver attractive, long-term, profitable growth."

Revolution Beauty expects to announce its results for the half year ended 31 August 2024 in November.

(1) Underlying Adjusted EBITDA for FY24 calculated as Adjusted EBITDA of £6.4m less stock provision benefit of £3.1m

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, please contact:

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

Joint Corporate Brokers

Panmure Liberum Capital Limited (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

Zeus: Benjamin Robertson / Nick Cowles / Jordan Warburton

Tel: +44 (0) 161 831 1512

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRARSSURRUA
Date   Source Headline
8th Jun 20267:00 amRNSNew Licensing Partnership with Debenhams Group
5th Jun 20267:00 amRNSFinancial Conduct Authority Update
16th Apr 20267:00 amRNSGrant of Share Options
1st Apr 202611:35 amRNSTotal Voting Rights
11th Mar 20267:00 amRNSAppointment of Nominated Adviser
2nd Mar 202611:28 amRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20263:48 pmRNSTotal Voting Rights
15th Dec 20256:18 pmRNSDirector/PDMR Shareholding
1st Dec 20255:43 pmRNSTotal Voting Rights
27th Nov 20253:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSInterim Results
26th Nov 20256:15 pmRNSRelated Party Transaction
4th Nov 20254:32 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20259:33 amRNSResult of AGM
24th Sep 20257:00 amRNSDirectorate Change
18th Sep 20257:00 amRNSHolding(s) in Company
17th Sep 202512:30 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSDirector/PDMR Shareholding
16th Sep 20255:17 pmRNSHolding(s) in Company
16th Sep 20259:11 amRNSHolding(s) in Company
11th Sep 20254:09 pmRNSResults of General Meeting
2nd Sep 20258:30 amRNSTotal Voting Rights
1st Sep 20255:06 pmRNSHolding(s) in Company
1st Sep 20258:33 amRNSHolding(s) in Company
29th Aug 20254:50 pmRNSFinal Results, Annual Report Posting & AGM Notice
26th Aug 20257:01 amRNSCircular Publication, Notice of GM & Board Update
26th Aug 20257:00 amRNSResult of Retail Offer to existing shareholders
22nd Aug 20254:31 pmRNSPDMR Dealing
22nd Aug 20253:30 pmRNSHolding(s) in Company
22nd Aug 20258:52 amRNSHolding(s) in Company
22nd Aug 20258:40 amRNSRetail Offer to existing shareholders
22nd Aug 20258:09 amRNSResult of Placing and Subscription
22nd Aug 20257:02 amRNSProposed Placing and Subscription via ABB
22nd Aug 20257:01 amRNSPreliminary Unaudited Results
22nd Aug 20257:00 amRNSTermination of Formal Sale Process
21st Aug 202510:51 amRNSForm 8.5 (EPT/RI)
20th Aug 202510:28 amRNSForm 8.5 (EPT/RI)
19th Aug 202512:27 pmRNSFY25 Trading Update
19th Aug 202510:01 amRNSForm 8.5 (EPT/RI)
18th Aug 202510:27 amRNSForm 8.5 (EPT/RI)
15th Aug 20254:11 pmRNSHolding(s) in Company
15th Aug 20259:57 amRNSForm 8.5 (EPT/RI)
14th Aug 202510:25 amRNSForm 8.5 (EPT/RI)
13th Aug 202510:31 amRNSForm 8.5 (EPT/RI)
12th Aug 202510:05 amRNSForm 8.5 (EPT/RI)
11th Aug 202510:26 amRNSForm 8.5 (EPT/RI)
8th Aug 202511:31 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.